San Diego, California
Professor of Surgery and Epidemiology
University of California San Diego, Johns Hopkins Bloomberg School of Public Health
Chief Vascular and Endovascular Surgery
University of California San Diego
SCHEDULE FOR VEITHsymposium™
Wednesday, November 15, 2023
Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
DEBATE: Not So: Ovation Stent-Grafts (From Endologix) Have Good 5-Year Results With No Neck Dilatation Or Migration Even With Challenging Neck Anatomy: Based On A Multicenter International Study Of A Low Profile Endograft
2:11 PM - 2:16 PM

View Slides in PDF
Friday, November 17, 2023
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
DEBATE: TCAR Versus CEA (Carotid Endarterectomy): 3-Year Results From A Large Propensity Matched VQI-Medicare Database Show Similar Stroke, And Death Rates At 3 Years For Symptomatic And Asymptomatic Patients: At 3-Years: TCAR Can Replace CEA More Widely
8:29 AM - 8:34 AM

View Slides in PDF
Presenter
SESSION 82: MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
Optimal Timing Of Carotid Revascularization (CEA, TFCAS, TCAR) After Symptom Onset: Within 48 Hours Stroke Risk Is Increased For All Procedures; After 48 Hours Risk Is Less With CEA And TCAR Than With TFCAS: Based On A Large National Database Study: Can Artificial Intelligence (AI) Help To Predict Stroke Risk
11:12 AM - 11:17 AM

View Slides in PDF
 
previous next